In our earlier studies, we showed that an escape mutant of mouse-adapted H9N2 influenza virus carrying a T198N amino acid change in heamagglutinin (HA) has a lowered virulence for mice. The readaptation of this mutant to mice was associated with N198S or N198D reverse mutations. In this study, single-gene reassortants having HA gene of the wild-type virus, its low-virulence escape mutant, or a readapted variant were generated by sitespecific mutagenesis and assayed for virulence. The results showed that antibody-selected mutations in the HA of H9 influenza virus can decrease mortality and virus accumulation in mouse lungs, though not in nasal turbinates, and the effect may be compensated by reverse mutations in the course of passaging.
Introduction
Influenza viruses of H9 subtype have been found mainly in birds, including domestic poultry [2] . However, H9 viruses have been reported to cause occasional respiratory disease in humans [4, 5, 13] . Understandably, this attracted attention to the characteristics of H9 influenza virus components, including the hemagglutinin (HA), an external viral glycoprotein that plays an essential role in anti-viral immunity as the primary target of neutralizing antibodies. The x-ray crystallographic structure of H9 HA has been presented and analyzed [6, 7] .
In our previous study, we mapped the antigenic epitopes of H9 HA by selecting escape mutants with monoclonal antibodies (MAbs) and characterizing the mutant HA by sequencing and immune cross-reactions [12] . We used a mouse-adapted variant of H9N2 virus, which allowed us to characterize the mutants with respect to their virulence for mice. Some of them were found to be less virulent than the mouse-adapted wild-type virus. The readaptation to mice by lung-to-lung passages restored the virulence to the wild-type level. The lowvirulence mutants had an amino acid change in the HA, T198N, leading to the acquisition of a potential glycosylation site, whereas the readaptation was associated with the loss of the glycosylation site as a result of N198S or N198D reverse amino acid changes [19] . This correlation of specific amino acid changes in the HA with decrease and restoration of virulence was suggestive but not sufficient to prove that these amino acid changes cause variations in virulence. The decrease in virulence might result from randomly co-selected mutations in genes other than HA, whereas the regaining of virulence could result from virulence-enhancing mutations in different viral genes during readaptation. To determine whether the mutations in the HA protein were alone sufficient for the decrease and restoration of virulence, single-gene reassortants had to be produced and characterized. In this study, such H9N1 reassortants were generated by site-specific mutagenesis (rg-PR8-HA-Sw/ HK/9/98-MA, rg-PR8-HA-m8C4, rg-PR8-HA-RAm8C4), and assayed for virulence (Table 1) .
The reverse-genetics reassortment was performed with the use of an 8-plasmid transfection system [8] . Three single-gene reassortant viruses containing seven genes of A/Puerto Rico/8/34 (H1N1) virus and the HA gene from the mouse-adapted A/Swine/Hong Kong/9/98 (H9N2) virus (A/Sw/HK/9/98-MA) [19] were rescued. The point mutations encoding substitutions in the HA of a low-virulence escape mutant (T198N) or in a readapted variant (N198D) were inserted by using a Quickchange site-directed mutagenesis kit (Stratagene), and the H9N1 reassortant viruses were generated by DNA transfection of 293T cells. The assay of mouse pneumovirulence was performed by determination of log 10 (EID 50 /MLD 50 ) as described in our earlier report [11] . To measure the virus accumulation in mouse tissues, the mice were infected intranasally with 10 6.5 EID 50 . Nasal turbinates (NT) and lungs were taken 72 h after infection, weighed, and homogenized in sterile PBS. The NT homogenate of each mouse was combined with nasal wash. The homogenates were clarified by lowspeed centrifugation, and virus infectivity was assayed by the method of Reed and Muench [18] .
The assay of mouse mortality revealed that the extent of the decrease in virulence in the reverse-genetic H9N1 single-gene reassortant carrying the escape mutation T198N (designated as rg-PR8-HA-m8C4) was of the same magnitude as the decrease observed for the original escape mutant m8C4 (Table 1 ). The single-gene reassortant rg-PR8-HA-RAm8C4 carrying the mutation encoding the substitution in the readapted variant RAm8C4(2) exhibited the restoration of virulence. The survival rate indicated that the virulence was restored to a level very close, although not exactly identical, to the initial one ( Fig. 1) .
The loss of virulence associated with the mutation T198N and the restoration of virulence associated with the mutation N198D as measured in log 10 (EID 50 /MLD 50 ) were on the order of 3 log 10 . The value of the loss and restoration of virulence registered for the site-specific mutants was of the same magnitude ( Table 1 ). The results showed that the amino acid changes in the H9 HA are sufficient for a drastic decrease in virulence and for the regaining of pathogenicity.
The comparison of the data on escape mutants and readapted variants [19] with the data on the site-specific mutants generated for our study was easy and demonstrative, because the virulence of the single-gene reassortant rg-PR8-HA-Sw/HK/9/98-MA proved to be very close or identical to the virulence of the wild-type virus A/Sw/HK/ 9/98-MA (H9N2) ( Table 1 ). This equality probably results from a fortunate coincidence: influenza A/Puerto Rico/8/34 (H1N1) (Mount Sinai) strain, which provided seven genes to the reassortant rg-PR8-HA-Sw/HK/9/98-MA, as shown in our earlier studies, has almost the same level of virulence for mice as does A/Sw/HK/9/98-MA (H9N2) [19, 20] . For this reason, the value of virulence of the reassortant rg-PR8-HA-Sw/HK/9/98-MA should be regarded as an expected one, since it coincides with the virulence of both parent viruses.
The measurement of virus accumulation in mouse lungs and NT revealed that variations in virulence as measured by mouse mortality corresponded qualitatively to the accumulation of virus in mouse lungs. However, the difference between accumulation in the lungs of mice infected with the low-virulence mutant and those infected with the wild-type virus (Table 2 ) was much smaller than the difference in mortality (Fig. 1, Table 1 ). Obviously, the a Amino acid changes (H3 numbering) in the escape mutant and the corresponding site-specific mutant are shown with respect to the wildtype sequence. Amino acid changes in the readapted variant and the corresponding site-specific mutant (in italics) are shown with respect to the sequence of the escape mutant b Expressed as log 10 (EID 50 /MLD 50 ) ± SE 9 t a,n-2 , where t a is Student's coefficient with probability a = 0.95 c Data published in [19] d Influenza viruses generated in this study 
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rg-PR8-HA-SW/HK/9/98-MA rg-PR8-HA-m8C4 rg-PR8-HA-RAm8C4 Fig. 1 Lethality of the recombinant H9N1 influenza viruses in mice. Survival of mice inoculated with 5 9 10 6 EID 50 of recombinant rgSw/HK/9/98-MA-PR8, rg-m8C4-PR8, or rg-RAm8C4-PR8 influenza viruses. The Kaplan-Meier method was used to estimate the probability of survival decrease in virus accumulation in the lungs by 1.3 log 10 was statistically significant (P \ 0.05) and sufficient to enable virus clearance and recovery. On the other hand, we did not register any statistically significant decrease of accumulation in NT of the low-virulence escape mutant (Table 2) ; that is, the degree of accumulation in the lungs was not predetermined by the extent of virus reproduction in the upper respiratory tract. This suggested that the decrease in virulence was caused by the impairment of virus reproduction in the lungs, regardless of the level of virus accumulation in NT.
In our previous studies [12] , we observed that the amino acid change in the HA of an escape mutant of the mouseadapted variant of a swine H9N2 virus leading to the acquisition of a new glycosylation site was associated with a sharp decrease in mouse pneumovirulence. The readaptation to mice by serial lung-to-lung passages led to a restoration of virulence associated with the loss of the glycosylation site [19] . The amino acid change in the readapted variants occurred at the same position as the mutation in the escape mutant and removed the potential glycosylation site, although it did not restore the initial wild-type amino acid sequence. The data indicated that the amino acid changes in the H9 HA might contribute to the change in virulence. However, they could not be regarded as rigorous proof of a cause-and-effect relationship between the mutations and the variations in virulence, because the effect of the mutations in other genes coselected during the production of escape mutants and, especially, during the readaptation could not be excluded.
Our findings showed that the antibody-selected mutations in the HA as well as the amino acid changes in the HA acquired during the readaptation are per se sufficient for the loss and restoration of virulence. It should be noted that on a general basis, these data do not exclude possible participation of genes other than HA in the regaining of virulence after a damaging mutation in HA. In the experiments described here, such effects were absent or too low to be revealed, but in other cases they may occur. The role of the mutations in genome segments 4, 5, 7, and 8 in the increase in virulence in mouse-adapted human influenza A virus has been reported [3] . However, our findings showed that the antibody-selected mutations had a loss of virulence and that the restoration of virulence in the course of virus passaging could be caused solely by amino acid changes in the HA, even in the absence of mutations in other genes.
Avian influenza viruses, such as H9 viruses, undergo rapid evolution, including antigenic and functional changes in HA [1, 9] . It is not known to what extent the mutations affecting the antigenicity are pleiotropic. The question is important, because H9 viruses have a tendency to acquire human-like receptor specificity [9, 12] . We showed in our earlier studies that a change of antigenicity may be associated with a change in affinity to sialic substrates [12] . The low-virulence escape mutant used in this study had been shown to have a decreased affinity to sialyl substrates, whereas the affinity in the readapted variant was restored to the wild-type level [12, 19] . It was shown in several studies [10, 15] that the cells of the mouse respiratory tract contain mostly the 2 0 -3 0 type of receptors. On the other hand, the variant of the human 1918 influenza virus possessing 2 0 -6 0 specificity was shown to be fatal for mice [17] . The decrease in the affinity to 2 0 -6 0 sialyl substrates produced by the mutation T198N did not induce a decrease in virus accumulation in NT, although it did correlate with a lower virus accumulation in mouse lungs (Table 2) . To interpret this finding in conjunction with the virus affinity to cell receptors in various parts of mouse respiratory tract, further progress is necessary in the analysis of the fine structures of cell receptors in the respiratory tract.
In a recently published report on the antigenic mapping of H9 HA [14] , escape mutants having amino acid changes in HA in eight positions were selected, and seven of them differed from the positions registered in our studies [12] . The mapping revealed five antigenic sites, three of them not overlapping with the sites found in our studies. No escape mutants with an amino acid change in position 198 (188 in H9 numbering) were selected. The strains the authors used were not pathogenic for laboratory animals, and they presented no data on the effects of the amino acid changes on the virulence or receptor specificity of their escape mutants.
Among 185 strains of natural H9 isolates registered in GenBank, 47 (mostly isolated from quail and other terrestrial birds) have Asn in position 198, like the escape mutant m8C4 in our studies. Most other H9 strains have either Thr or Ala in this position. Unlike several other amino acid substitutions in the HA of H9 strains, the presence of Asn198 has not been identified as involved in the host adaptation [16] . It is not known whether this amino acid substitution in natural isolates resulted from immune pressure or whether it had any pleiotropic effects, including the modification of virulence. Our findings obtained with the use of site-specific mutations and single-gene reassortants show that an antibody-selected mutation in the HA of an influenza virus may reduce virulence and that this effect may be reversed by mutations in the HA in the course of further virus dissemination. This observation may become especially significant if H9 influenza virus ever crosses the barrier between swine and humans, like the newly emerged H1N1 swine influenza viruses [21] .
